Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain
Clinical trial NCT04149067 · COMPLETED
Trial details
- NCT number
- NCT04149067
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-05
- Primary completion
- 2019-03-15
- Enrollment
- 1080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.